Michaelis, Katherine A. http://orcid.org/0000-0002-3225-3649
Norgard, Mason A.
Zhu, Xinxia
Levasseur, Peter R.
Sivagnanam, Shamilene
Liudahl, Shannon M.
Burfeind, Kevin G.
Olson, Brennan
Pelz, Katherine R.
Angeles Ramos, Diana M.
Maurer, H. Carlo http://orcid.org/0000-0002-2193-6014
Olive, Kenneth P.
Coussens, Lisa M.
Morgan, Terry K.
Marks, Daniel L. http://orcid.org/0000-0003-2675-7047
Funding for this research was provided by:
EIF | Stand Up To Cancer (SU2C-AACR-DT14-14)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA217989-01, R01CA184324-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Brenden-Colson Center for Pancreatic Care
Article History
Received: 29 January 2019
Accepted: 18 September 2019
First Online: 15 October 2019
Change Date: 15 November 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: L.M.C. declares that she is a paid consultant for Cell Signaling Technologies and received reagent support from NanoString Technologies. L.M.C. is a member of the Scientific Advisory Boards of Syndax Pharmaceuticals, Inc., Carisma Therapeutics, Inc., and Verseau Therapeutics, Inc. D.L.M. declares that he is a paid consultant for Pfizer, Inc.